SCHEMBL7420992

SCHEMBL7420992

COC(=O)/C=C/c1c[nH]c2cc(C(=O)OC)ccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.54
TDO2 P48775 1/20 0.49
ASH1L Q9NR48 1/20 0.47
KIF11 P52732 1/20 0.47
RAB9A P51151 5/20 0.45
ALDH1A1 P00352 5/20 0.45
MAPT P10636 5/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
PKM P14618 1/20 0.45
ALOX12 P18054 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419015 1.00 NPC1 (0.54) NPC1TDO2ASH1LKIF11RAB9A
SCHEMBL7471670 0.90 NPC1 (0.54) NPC1TDO2ASH1LKIF11RAB9A
SCHEMBL7471673 0.90 NPC1 (0.54) NPC1TDO2ASH1LKIF11RAB9A
SCHEMBL18918119 0.85 NPC1 (0.52) NPC1TDO2ASH1LKIF11RAB9A
SCHEMBL18918116 0.85 NPC1 (0.52) NPC1TDO2ASH1LKIF11RAB9A
SCHEMBL9377444 0.84 BACE1 (0.54) TDO2ALDH1A1MAPTMEN1KMT2A
SCHEMBL9377450 0.84 BACE1 (0.54) TDO2ALDH1A1MAPTMEN1KMT2A
SCHEMBL27519422 0.84 BACE1 (0.54) TDO2ALDH1A1MAPTMEN1KMT2A
SCHEMBL15323184 0.84 MAPT (0.58) NPC1TDO2RAB9AALDH1A1MAPT
SCHEMBL212820 0.83 PLG (0.61) NPC1ASH1LKIF11RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed